Пресса | HIPRA

who we are

Пресса

09/13/2021 - 18:48

HIPRA signs an agreement to supply 50 millions doses of Covid-19 vaccine to Vietnam

Медицина

Узнать подробнее

09/10/2021 - 12:47

HIPRA acquires GoodGut and strengthens its Human Health division

Медицина

Узнать подробнее

08/27/2021 - 08:46

The clinical trial of the HIPRA vaccine against Covid-19 is progressing with the administration of the first doses to humans

Медицина

Узнать подробнее

04/16/2021 - 15:44

HIPRA plans to produce 400 million doses of its SARS-CoV-2 HIPRA vaccine during 2022

Медицина

Узнать подробнее

12/11/2020 - 11:43

HIPRA takes a firm step towards human health with research and manufacture of a Covid-19 vaccine

Медицина

Узнать подробнее

09/21/2020 - 09:28

HIPRA is researching a new vaccine for Covid-19 based on virus mRNA

Медицина

Узнать подробнее